1834 INVESTMENT ADVISORS CO - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 200 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
1834 INVESTMENT ADVISORS CO ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$30,000
-18.9%
3,0000.0%0.00%
-20.0%
Q1 2022$37,000
-50.0%
3,000
-7.7%
0.01%
-37.5%
Q4 2021$74,000
-14.0%
3,250
-16.7%
0.01%
-20.0%
Q3 2021$86,000
+38.7%
3,900
-18.8%
0.01%
+42.9%
Q2 2021$62,000
+59.0%
4,800
+60.0%
0.01%
+40.0%
Q1 2021$39,0003,0000.01%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders